Literature DB >> 20452379

Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.

Boris Pastorino1, Antoine Nougairède, Nathalie Wurtz, Ernest Gould, Xavier de Lamballerie.   

Abstract

The genus Flavivirus contains approximately 70 arthropod-borne enveloped RNA viruses many of which cause severe human and in some cases, animal disease. They include dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, and tick-borne encephalitis virus. Hundreds of thousands of deaths due to flavivirus infections occur each year, many of which are unpreventable due to lack of availability of appropriate vaccines and/or antiviral drugs. Flaviviruses exploit the cytoplasmic cellular machinery to facilitate propagation of infectious progeny virions. They engage in dynamic and antagonistic interactions with host cell membranes and biochemical processes. Following infection, the cells initiate various antiviral strategies to counteract viral invasion. In its defense, the virus has alternative strategies to suppress these host responses to infection. The fine balance between these interactions determines the outcome of the viral infection and disease progression. Published studies have revealed specific effects of flaviviruses on cellular processes, but the underlying mechanisms that determine the specific cytopathogenetic changes induced by different flaviviruses have not, as yet, been elucidated. Independently of the suppression of the type I IFN response which has been described in detail elsewhere, this review focuses on recent discoveries relating to alterations of host metabolism following viral infection. Such studies may contribute to new approaches to antiviral drug development. The role of host cellular factors will be examined in the context of protection and/or pathogenesis resulting from flavivirus infection, with particular emphasis on West Nile virus and dengue virus. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452379     DOI: 10.1016/j.antiviral.2010.04.014

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  29 in total

1.  Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses.

Authors:  Mateusz Kudelko; Jean-Baptiste Brault; Kevin Kwok; Ming Yuan Li; Nathalie Pardigon; J S Malik Peiris; Roberto Bruzzone; Philippe Desprès; Béatrice Nal; Pei Gang Wang
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

2.  Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles.

Authors:  Corey A Balinsky; Hana Schmeisser; Sundar Ganesan; Kavita Singh; Theodore C Pierson; Kathryn C Zoon
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  High-content assay to identify inhibitors of dengue virus infection.

Authors:  David Shum; Jessica L Smith; Alec J Hirsch; Bhavneet Bhinder; Constantin Radu; David A Stein; Jay A Nelson; Klaus Früh; Hakim Djaballah
Journal:  Assay Drug Dev Technol       Date:  2010-10       Impact factor: 1.738

Review 4.  The Use of Ex Vivo Organ Cultures in Tick-Borne Virus Research.

Authors:  Jeffrey M Grabowski; Danielle K Offerdahl; Marshall E Bloom
Journal:  ACS Infect Dis       Date:  2018-02-23       Impact factor: 5.084

5.  The eukaryotic translation initiation factor 3 subunit L protein interacts with Flavivirus NS5 and may modulate yellow fever virus replication.

Authors:  Ana Ts Morais; Ana Cb Terzian; Danilo Vb Duarte; Roberta Vm Bronzoni; Maria Cfs Madrid; Arieli F Gavioli; Laura Hvg Gil; Amanda G Oliveira; Cleslei F Zanelli; Sandro R Valentini; Paula Rahal; Mauricio L Nogueira
Journal:  Virol J       Date:  2013-06-22       Impact factor: 4.099

6.  Additive protection by antioxidant and apoptosis-inhibiting effects on mosquito cells with dengue 2 virus infection.

Authors:  Tien-Huang Chen; Yin-Ping Lo; Chao-Fu Yang; Wei-June Chen
Journal:  PLoS Negl Trop Dis       Date:  2012-04-17

Review 7.  Host cell factors as antiviral targets in arenavirus infection.

Authors:  Florencia N Linero; Claudia S Sepúlveda; Federico Giovannoni; Viviana Castilla; Cybele C García; Luis A Scolaro; Elsa B Damonte
Journal:  Viruses       Date:  2012-09-13       Impact factor: 5.048

8.  Dengue-specific subviral nanoparticles: design, creation and characterization.

Authors:  Niyati Khetarpal; Ankur Poddar; Satish K Nemani; Nisha Dhar; Aravind Patil; Priyanka Negi; Ashiya Perween; Ramaswamy Viswanathan; Heinrich Lünsdorf; Poornima Tyagi; Rajendra Raut; Upasana Arora; Swatantra K Jain; Ursula Rinas; Sathyamangalam Swaminathan; Navin Khanna
Journal:  J Nanobiotechnology       Date:  2013-05-25       Impact factor: 10.435

Review 9.  Carbohydrate-related inhibitors of dengue virus entry.

Authors:  Kazuya I P J Hidari; Tomoko Abe; Takashi Suzuki
Journal:  Viruses       Date:  2013-02-06       Impact factor: 5.048

10.  Heat shock protein 70 is associated with replicase complex of Japanese encephalitis virus and positively regulates viral genome replication.

Authors:  Jing Ye; Zheng Chen; Bo Zhang; Huan Miao; Ali Zohaib; Qiuping Xu; Huanchun Chen; Shengbo Cao
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.